EUVIMEDEUVIMED entdecken
Crossref

EVALUATION OF LIVER FUNCTION INDICES IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY: DIAGNOSTIC UTILITY AND NEONATAL OUTCOMES

Gülşan Karabay, Zeynep Şeyhanlı, Serap Topkara Sucu, Betül Tokgöz, Gizem Aktemur, Nazan Vanlı Tonyalı, Umut Karabay, Selver Özge Şefik, Gulsah Dagdeviren, Şevki Çelen

Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · 22.01.2025 · 57 (3) · 114-119

DOI: 10.20492/aeahtd.1495698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, online erschienen am 22.01.2025. Verfasst von Gülşan Karabay und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Intrahepatic cholestasis of pregnancy (ICP) is a hepatic condition that occurs in 0.2-2% of pregnancies. It is characterized by intense itching and increased levels of bile acids in the bloodstream. Precise identification and anticipation of adverse neonatal outcomes are crucial. This study evaluates the diagnostic performance of liver-related scores—APRI (aspartate aminotransferase- platelet), ALBI (albumin-bilirubin), PALBI (platelet- albumin-bilirubin), and FAR (fibrinogen/albumin ratio) —in ICP patients and examines their relationship to pregnancy outcomes. Material and Method: This study was a retrospective analysis of 180 patients who were treated at Ankara Etlik City Hospital between January 2023 and January 2024. 90 ICP patients (Group 1) and 90 control patients (Group 2) were compared. The PALBI, ALBI, APRI scores, and FAR were calculated using third-trimester laboratory values. Neonatal outcomes, including birth weight, APGAR scores, NICU (neonatal intensive care unit) admission, sepsis, RDS (respiratory distress syndrome), and neonatal death were recorded. Statistical analyses included ROC (Receiver Operating Characteristics) curve analysis and Spearman correlation.

Results

The PALBI, ALBI, APRI scores, and FAR were significantly higher in ICP patients (p-2.58 for PALBI (sensitivity 62%, specificity 81%), >-2.47 for ALBI (sensitivity 67%, specificity 81%), and >0.3 for APRI (sensitivity 78%, specificity 68%). Neonatal outcomes did not differ significantly between the groups. There was no correlation between fasting bile acid levels and liver damage markers with negative outcomes in newborns.

Conclusion

In facilities where it is not possible to test fasting bile acid levels, PALBI, ALBI, APRI scores and FAR value offer an alternative approach to the evaluation of individuals with intrahepatic cholestasis of pregnancy (ICP). Future studies with larger patient groups are needed to increase the reliability of these parameters.

Zitieren

APA

Karabay, G., Şeyhanlı, Z., Sucu, S. T., Tokgöz, B., Aktemur, G., Tonyalı, N. V., Karabay, U., Şefik, S. Ö., Dagdeviren, G., & Çelen, Ş. (2025). EVALUATION OF LIVER FUNCTION INDICES IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY: DIAGNOSTIC UTILITY AND NEONATAL OUTCOMES. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, 57(3), 114-119. https://doi.org/10.20492/aeahtd.1495698

Vancouver

Karabay G, Şeyhanlı Z, Sucu ST, Tokgöz B, Aktemur G, Tonyalı NV, et al. EVALUATION OF LIVER FUNCTION INDICES IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY: DIAGNOSTIC UTILITY AND NEONATAL OUTCOMES. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. 2025;57(3):114-119. doi:10.20492/aeahtd.1495698

BibTeX
@article{Karabay2025,
  author = {Karabay, Gülşan and Şeyhanlı, Zeynep and Sucu, Serap Topkara and Tokgöz, Betül and Aktemur, Gizem and Tonyalı, Nazan Vanlı and Karabay, Umut and Şefik, Selver Özge and Dagdeviren, Gulsah and Çelen, Şevki},
  title = {EVALUATION OF LIVER FUNCTION INDICES IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY: DIAGNOSTIC UTILITY AND NEONATAL OUTCOMES},
  journal = {Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi},
  year = {2025},
  volume = {57},
  number = {3},
  pages = {114--119},
  doi = {10.20492/aeahtd.1495698}
}
Kostenlos starten →